DOSAGE REGIMEN FOR PEGYLATED INTERFERON

• 收藏
• 分享

专利权人:

PharmaEssentia Corporation

发明人:

Christoph Klade,Oleh Zagrijtschuk,Ko-Chung Lin

申请号：

US15518423

公开号：

US20170326206A1

申请日:

2015.11.06

申请国别(地区):

US

年份:

2017

代理人:

摘要：

A pegylated type I interferon for use in treating an infectious disease, cancer, or myeloproliferative disease in a subject in need thereof, wherein a 50 to 540 μg dose of the pegylated type I interferon is administered to the subject at a regular interval for a treatment period, the interval being 3 to 8 weeks.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/